| Bioactivity | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 (L-threo-2,6-Diaminopimelic acid-13C7,15N2) is 13C and 15N-labeled (2S,6S)-2,6-diaminoheptanedioic acid (HY-W334800). |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 0 --> (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 相关抗体: |
| Name | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 |
| CAS | 1334376-68-9 |
| Formula | 13C7H1415N2O4 |
| Molar Mass | 199.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
(2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2
CAS: 1334376-68-9 F: 13C7H1415N2O4 W: 199.13
(2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 (L-threo-2,6-Diaminopimelic acid-13C7,15N2) is 13C and 15N-labeled (2S,6S
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.